Investigational Site Number : 7240009

Madrid 28041

1 studies enrolling now · 2 studies all time

What they study most

COVID-19, Type 1 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes — Recruiting now
• Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older — Completed